189 related articles for article (PubMed ID: 20693983)
1. β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast.
Lacroix-Triki M; Geyer FC; Lambros MB; Savage K; Ellis IO; Lee AH; Reis-Filho JS
Mod Pathol; 2010 Nov; 23(11):1438-48. PubMed ID: 20693983
[TBL] [Abstract][Full Text] [Related]
2. β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation.
Geyer FC; Lacroix-Triki M; Savage K; Arnedos M; Lambros MB; MacKay A; Natrajan R; Reis-Filho JS
Mod Pathol; 2011 Feb; 24(2):209-31. PubMed ID: 21076461
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast.
Dunne B; Lee AH; Pinder SE; Bell JA; Ellis IO
Hum Pathol; 2003 Oct; 34(10):1009-15. PubMed ID: 14608534
[TBL] [Abstract][Full Text] [Related]
4. Expression of p40 and laminin 332 in metaplastic spindle cell carcinoma of the breast compared with other malignant spindle cell tumours.
D'Alfonso TM; Ross DS; Liu YF; Shin SJ
J Clin Pathol; 2015 Jul; 68(7):516-21. PubMed ID: 25795733
[TBL] [Abstract][Full Text] [Related]
5. Genetic changes of Wnt pathway genes are common events in metaplastic carcinomas of the breast.
Hayes MJ; Thomas D; Emmons A; Giordano TJ; Kleer CG
Clin Cancer Res; 2008 Jul; 14(13):4038-44. PubMed ID: 18593979
[TBL] [Abstract][Full Text] [Related]
6. Low-grade fibromatosis-like spindle cell carcinomas of the breast are molecularly exiguous.
Takano EA; Hunter SM; Campbell IG; Fox SB
J Clin Pathol; 2015 May; 68(5):362-7. PubMed ID: 25713418
[TBL] [Abstract][Full Text] [Related]
7. Recent developments in the histological diagnosis of spindle cell carcinoma, fibromatosis and phyllodes tumour of the breast.
Lee AH
Histopathology; 2008 Jan; 52(1):45-57. PubMed ID: 18171416
[TBL] [Abstract][Full Text] [Related]
8. The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours.
Sawyer EJ; Hanby AM; Rowan AJ; Gillett CE; Thomas RE; Poulsom R; Lakhani SR; Ellis IO; Ellis P; Tomlinson IP
J Pathol; 2002 Apr; 196(4):437-44. PubMed ID: 11920740
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of the CTNNB1 mutation genotype in surgically resected fibromatosis of the breast.
Kim T; Jung EA; Song JY; Roh JH; Choi JS; Kwon JE; Kang SY; Cho EY; Shin JH; Nam SJ; Yang JH; Choi YL
Histopathology; 2012 Jan; 60(2):347-56. PubMed ID: 22211293
[TBL] [Abstract][Full Text] [Related]
10. p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma.
Koker MM; Kleer CG
Am J Surg Pathol; 2004 Nov; 28(11):1506-12. PubMed ID: 15489655
[TBL] [Abstract][Full Text] [Related]
11. Stromal keratin expression in phyllodes tumours of the breast: a comparison with other spindle cell breast lesions.
Chia Y; Thike AA; Cheok PY; Yong-Zheng Chong L; Man-Kit Tse G; Tan PH
J Clin Pathol; 2012 Apr; 65(4):339-47. PubMed ID: 22259180
[TBL] [Abstract][Full Text] [Related]
12. Fibromatosis of the breast and mutations involving the APC/beta-catenin pathway.
Abraham SC; Reynolds C; Lee JH; Montgomery EA; Baisden BL; Krasinskas AM; Wu TT
Hum Pathol; 2002 Jan; 33(1):39-46. PubMed ID: 11823972
[TBL] [Abstract][Full Text] [Related]
13. Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis.
Montgomery E; Torbenson MS; Kaushal M; Fisher C; Abraham SC
Am J Surg Pathol; 2002 Oct; 26(10):1296-301. PubMed ID: 12360044
[TBL] [Abstract][Full Text] [Related]
14. Fibroepithelial lesions; The WHO spectrum.
Krings G; Bean GR; Chen YY
Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
[TBL] [Abstract][Full Text] [Related]
15. Metaplastic carcinomas of the breast: diagnostic challenges and new translational insights.
Rungta S; Kleer CG
Arch Pathol Lab Med; 2012 Aug; 136(8):896-900. PubMed ID: 22849737
[TBL] [Abstract][Full Text] [Related]
16. Beta-catenin abnormalities and associated insulin-like growth factor overexpression are important in phyllodes tumours and fibroadenomas of the breast.
Sawyer EJ; Hanby AM; Poulsom R; Jeffery R; Gillett CE; Ellis IO; Ellis P; Tomlinson IP
J Pathol; 2003 Aug; 200(5):627-32. PubMed ID: 12898599
[TBL] [Abstract][Full Text] [Related]
17. Expression of lymphoid enhancer-binding factor 1 in breast fibroepithelial lesions.
Chen PH; Bossuyt V; Reisenbichler E
Hum Pathol; 2021 Feb; 108():68-75. PubMed ID: 33245988
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature.
Carlson JW; Fletcher CD
Histopathology; 2007 Oct; 51(4):509-14. PubMed ID: 17711447
[TBL] [Abstract][Full Text] [Related]
19. Nuclear β-catenin localization and mutation of the CTNNB1 gene: a context-dependent association.
Kim G; Kurnit KC; Djordjevic B; Singh C; Munsell MF; Wang WL; Lazar AJ; Zhang W; Broaddus R
Mod Pathol; 2018 Oct; 31(10):1553-1559. PubMed ID: 29795437
[TBL] [Abstract][Full Text] [Related]
20. Myofibroblastic, fibroblastic and myoid lesions of the breast.
Krings G; McIntire P; Shin SJ
Semin Diagn Pathol; 2017 Sep; 34(5):427-437. PubMed ID: 28751104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
